CIRCARE Testimony, Invited Presentations, and Public Comments

2013-09-08: CIRCARE Public Comments In re: U.S. Department of Health and Human Services Request for Comments on Matters Related to the Protection of Human Subjects and Research Studying Standard of Care Interventions Docket HHS-OPHS-2013-0004 78 FR 38343 2013-09-08: http://www.circare.org/submit/circare_hhs-ophs-201300040001.pdf

2012-02-21: CIRCARE In re: U.S. Department of Homeland Security, Notice and request for comment, Docket No DHS-2011-0074, 76 Fed. Reg. 81,517 (2011) http://www.circare.org/submit/circare_submission-dhs.pdf

2011-12-04: CIRCARE In re: Office of Science and Technology Policy, Notice, Request for Information: Building A 21st Century Bioeconomy, 76 Fed. Reg. 62,869 (2011) http://www.circare.org/submit/circare_ostp_rfi_20111204.pdf

2011-09-21: CIRCARE In re: Docket No. HHS–OPHS–2011–0005, Advance Notice of Proposed Rulemaking, Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators, 76 Fed. Reg. 44,512 (2011) http://www.circare.org/submit/circare_anprm_response_201109.pdf

2011-05-02: Public Comments to The Presidential Commission for the Study of Bioethical Issues, RE: Federal Register 76:41 (March 2, 2011) pp. 11482-11483 http://www.circare.org/submit/public_comment_20110502.pdf

2005-12-05: CIRCARE public comments to the Office for Human Research Protections Draft Guidance on Reporting and Reviewing Adverse Events and Unanticipated Problems. Available from http://www.circare.org/submit/ohrpdraftguidance_20051117.doc

2005-08-02: CIRCARE Presentation to the Secretary's Advisory Committee on Human Research Protection by Paul Gelsinger, CIRCARE Vice President. Available from http://www.circare.org/submit/sachrp_20050802.pdf

2005-04-18: CIRCARE Public Comments to the Secretary's Advisory Committee on Human Research Protection by Michael A. Susko, CIRCARE President. Available from http://www.circare.org/submit/sachrp_pubcom2005.pdf

2005-02-21: CIRCARE Testimony submitted to FDA Docket 2005N-0038 Public Meeting on Adverse Event Reporting to Institutional Review Boards. Available from http://www.circare.org/submit/FDA_Docket2005N-0038.pdf

Transcript of FDA Public Meeting on Adverse Event Reporting to Institutional Review Boards. 2005-03-21.
Transcript Part I. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-01-vol4.pdf
Transcript Part II. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-02-vol4.pdf
Transcript Part III. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-03-vol4.pdf

2003-07-09: CIRCARE Testimony before the Institute of Medicine panel on Clinical Research Involving Children by Paul Gelsinger, CIRCARE Vice President and Adil Shamoo Ph.D., CIRCARE Co-Founder. Available from http://www.iom.edu/?id=13803

Testimony and associated material presented at the IOM panel on Clinical Research Involving Children: Open Session Agenda Meeting of 2003-07-09: http://www.iom.edu/?id=13665

Index of Meetings of the IOM Panel on Clinical Research Involving Children: http://www.iom.edu/?id=4864

2002-04-23: Testimony before the United States Senate Health, Education, Labor and Pensions Committee by Cherlynn Mathias R.N., CIRCARE Board of Directors. Available from http://www.circare.org/submit/230402Ch.pdf

2002-04-23: CIRCARE statement submitted to the United States Senate Health, Education, Labor and Pensions Committee by Adil Shamoo Ph.D., CIRCARE Co-Founder and Michael A. Susko, CIRCARE President. Available from http://www.circare.org/submit/230402Shamoo.pdf

S. Hrg. 107-424 Protecting Human Subjects in Research: Are Current Safeguards Adequate? Subcommittee on Public Health of the Senate Committee on Health, Education, Labor, and Pensions. 107th Congress Second Session. 2002-04-23. Accessed on 2009-03-11 at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_senate_hearings&docid=f:79325.pdf

2002-04-03: CIRCARE Testimony in Support of Maryland House Bill 917 by Michael A. Susko, CIRCARE President. Available from http://www.circare.org/submit/40302MSt.pdf

1999-04-21: CIRCARE Testimony before the Subcommittee on Oversight and Investigation, Committee on Veterans Affairs by Adil Shamoo Ph.D., CIRCARE Co-Founder, on The Unethical Use of Human Beings in High Risk Research Experiments. Available from http://veterans.house.gov/hearings/schedule106/apr99/4-21-99J/shamoo.htm

Subcommittee on Oversight and Investigation, Committee on Veterans Affairs. Hearing on the suspension of medical research at the West Los Angeles and Sepulveda VA medical facilities. 1999-04-21: http://veterans.house.gov/hearings/schedule106/apr99/4-21-99J/news.htm

1998-04-22: CIRCARE Testimony before the House Committee on Government Reform and Oversight. by Adil Shamoo Ph.D., CIRCARE C0-Founder. Available from http://web.archive.org/web/20000818170520/http://www.house.gov/reform/hearings/healthcare/fda498/shamoo.pdf

Hrg. No. 105-138 — Clinical Trial Subjects: Adequate FDA Protections? House Committee on Government Reform and Oversight. 105th Congress Second Session. 1998-04-22: http://www.access.gpo.gov/congress/house/pdf/105hrg/49827.pdf

1997-09-18: CIRCARE Testimony before the National Bioethics Commission Human Subjects Subcommittee. Available from http://bioethics. georgetown.edu/nbac/transcripts/sep97/human.pdf

top

Last Updated: 2013-09-08

If you find the information on this page helpful, please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page

---